Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists create pigs resistant to PRRS
PRRS can lead to severe breathing problems in piglets and breeding failures in pregnant females.
Gene-editing technique could improve animal health

Scientists have used advanced gene editing techniques to create pigs that show signs of resistance to a major viral disease.

Writing in the journal Plos Pathogens, researchers describe how they produced pigs that are completely resistant to porcine reproductive and respiratory syndrome (PRRS).

The team claims the pigs are otherwise healthy and the change introduced using gene-editing technology should not affect their ability to stave off other infections.

“Genome-editing offers opportunities to boost food security be reducing waste and losses from infectious diseases, as well as improving animal welfare by reducing the burden of disease,” explained lead researcher Professor Alan Archibald of The Roslin Institute.

PRRS can lead to severe breathing problems in piglets and breeding failures in pregnant females. Endemic in most pig-producing companies, vaccines have, on the whole, failed to prevent the spread of the virus. In Europe alone, the disease is thought to cost the industry some €1.5billion every year.

Research conducted in the past shows that the PRRS virus targets immune cells called macrophages. A molecule on the surface of these cells called CD163 is essential in enabling the PRRS virus to establish an infection.

In the study, scientists used a gene editing tool called CRISPR/Cas9 to cut out a small section of the CD163 gene in the pigs’ DNA that interacts with the PRRS virus. Research shows that this change prevents the virus from causing infection.

Professor Bruce Whitelaw, interim director of the Roslin Institute described the project as an ‘elegant demonstration’ of how precise genome editing can be.

“We have deleted a single exon from the CD163 gene. The opportunity to use this technology to Improve animal health and productivity presents an exciting approach to address the food security and one health challenges,” he said.

The study was funded by the Biotechnology and Biological Sciences Research (BBSRC) Animal Research Club and Genus. 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.